Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental design.

"Disclosure statement C. de Roos receives income for training postdoctoral professionals in EMDR. No potential conflict of interest was reported by the other authors."

"Method: A multiple-baseline single-case experimental design (n = 8) was used. Daily repeated measurements for FCR were taken during the baseline phase and treatment phase, post-treatment, and at the 3 month follow-up. Participants answered the Cancer Worry Scale (CWS) and the Fear of Cancer Recurrence Inventory, Dutch version (FCRI-NL) five times, i.e. at the start and at the end of each phase (baseline, treatment, post-treatment, and follow-up). The study was prospectively registered at clinicaltrials.gov (NL8223). Ethics approval: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Medical Ethics Committee South West Holland (P19.058 13-11-2019). The trial was registered at the Dutch Trial Register (NTR) (NL68358.058.19) as the FREE study: Effectiveness of EMDR for Fear of cancer Recurrence. Informed consent was obtained from all subjects involved in the study."